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doi:10.1016/j.nutres.2plasma homocysteine (Hcy). We conducted a cross-sectional study covering 2 periods, before and
after fortification (2002-2003 and 2008-2009, respectively), to assess the influence of the
consumption of corn and wheat flours prefortification and postfortification with folic acid on Hcy
levels and other biomarkers. In the total, 93 women (38 prefortification and 55 postfortification) were
included. Levels of lipids and glucose, total Hcy and serum folate, and cobalamin were determined
using commercial kits by colorimetric method, competitive immunoassay, and chemiluminescence,
respectively The participants' average age was 48.1 ± 9.5 years for the prefortification group and
39.1 ± 4.1 years for the postfortification group (P b .001) but adjusted statistical tests by age. Both
groups presented obesity class 1. In the prefortification group, 71.1% (n = 27) of women had a
dietary intake of folate, which was lower than the current recommended for adults (b400 μg/d),
whereas in the postfortification group, only 16.4% (n = 9) of women had lower intakes than
recommended. In the prefortification group, 42.1% (n = 16) of women had hyperhomocysteinemia
(N10 mmol/L) compared with only 9.1% (n = 5) in the postfortification group. Moreover, statistically
significant differences were found between the 2 groups in total cholesterol, high-density lipoprotein,
triglycerides, and dietary fiber. Our findings corroborate the hypothesis that fortification of wheat
and corn flours with folic acid can possibly be associated with lower concentrations of plasma Hcy,
providing probable greater cardiovascular protection in this group.
© 2011 Elsevier Inc.Open access under the Elsevier OA license.Keywords: Hyperhomocysteinemia; Folic acid; Cardiovascular disease; Obesity; Human
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; FFQ, food frequency questionnaire; Hcy, homocysteine;
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein; MS, metabolic syndrome.1. Introduction
It is estimated that folic acid can reduce the risk of
ischemic heart disease by 16%, deep vein thrombosis byuthor. Nutrition and Dietetic Department, Institute of
tro, Federal University of Rio de Janeiro, Av. Carlos




Open access under the Elsevier OA license.25%, and stroke by 24%. Although the causal association
between homocysteine (Hcy), folate, and stroke cannot be
deduced from epidemiological observations, available data
reinforce the hypothesis that folic acid fortification helps to
reduce mortality from stroke by at least the level of primary
prevention [1,2].
Because of the lower bioavailability of folic acid from
food, it is unlikely that only a diet could be sufficient to
increase the plasma concentrations of folate and reduce the
890 M. Scorsatto et al. / Nutrition Research 31 (2011) 889–895concentration of Hcy [3]. On the other hand, when food
fortification is performed, the bioavailability of this vitamin
is larger and able to reduce Hcy levels, as shown in the
results of this study.
Folic acid can be consumed as a supplement for high-risk
patients, and it comes to the general public through food
fortification or a combination of both [4]. The bioavailability
of this vitamin for intestinal absorption, when in the form of
supplements or fortified food, is approximately 85%,
whereas for dietary folate, the bioavailability is approxi-
mately 50% [5].
Folate deficiency affects a substantial proportion of the
population, especially adolescents, the institutionalized
elderly, and people of lower classes [6]. In addition, the
folate seems to react with some medications such as antacids,
oral contraceptives, anticonvulsants, aspirin, and its de-
rivatives, which increases gastric pH, forming complexes
poorly absorbed by decreasing the bioavailability of this
vitamin [7].
The US Food and Drug Administration implemented in
1998, a program to fortify whole flour and cereal products
with folic acid (140 μg/100 g of product) to increase the
daily intake of this vitamin in the general population, with
emphasis on women of reproductive age [8]. In Brazil, this
practice was adopted in June 2004 following a resolution of
the National Agency for Sanitary Vigilance to fortify corn
and wheat flours with folic acid and iron (150 μg and 4.2 mg
of 100 g of flours, respectively) [9].
Although the rules of mandatory fortification of wheat
and corn flours with folic acid were approved in Brazil,
research conducted by Soeiro et al [10] showed that
concentrations of folic acid were lower in samples of
wheat flours. However, corn flours presented extremely high
values than that recommended in the Brazilian legislation. In
addition, poor homogenization of folic acid in enriched
flours was observed [10].
In a population that consumes folic acid supplements or
has a diet fortified with this vitamin, the upper reference limit
of Hcy is usually 20% to 25% lower than in unfortified
populations. A study investigating the association between
hyperhomocysteinemia and cardiovascular disease (CVD),
serum folate, and cobalamin should also be analyzed [11].
The effectiveness of folic acid fortification in improving
folate status has already been shown to be quite striking, with
a dramatic increase in blood measurements of folate and a
substantial decrease in plasma Hcy levels in the United
States [12].
In Brazil, no study has been conducted comparing the
plasma concentrations of Hcy before and after the fortifica-
tion of flour with folic acid in women with metabolic
syndrome (MS). Thus, the hypothesis of this research is that
the fortification of flour with folic acid contributes to the
reduction of plasma Hcy levels. Therefore, the objective of
this study is to assess the effect of the consumption of corn
and wheat flours fortified with folic acid on Hcy levels and
other biomarkers in women by a cross-sectional studycovering 2 periods, prefortification and postfortification
in Brazil.2. Methods and materials
2.1. Subjects
A cross-sectional study was conducted in which partic-
ipants were recruited from 2 different stages: prefortification
(2002-2003) and postfortification (2008-2009) of flours with
folic acid.
The study was performed with patients of the Nutritional
Ambulatory Care of the Federal University of Rio de Janeiro,
Brazil, where overweight patients with chronic diseases were
being treated. They belonged to the lowest social classes and
were residents in several cities in the state of Rio de Janeiro.
Only women with MS were selected for this study because
they surpassed men in rates of cardiovascular mortality
in Brazil.
The 38 volunteers from the prefortification stage were
selected from a study with 93 individuals, which were
designed to assess the factors associated with Hcy levels in
individuals with and without MS [13]. From this study, only
women who met the inclusion criteria were included in this
research. The 55 volunteers from the postfortification stage
were selected from a study of 133 women. This study was
designed to assess the association between concentrations of
Hcy and biomarkers of MS. Included were those who filled
out a food frequency questionnaire (FFQ) [14]; the others
were excluded.
In both studies, after the screening, the explanation of the
research was given to the patients who met the eligibility
criteria. They signed a statement of consent and filled out a
general information questionnaire. Subsequently, blood
draw and anthropometric measurements were performed.
Lastly, the FFQ was applied.
2.2. Subject criteria
Inclusion criteria were the following: women nutritionally
diagnosed as overweight, obesity classes 1 and 2, with body
mass index (BMI) from 25.0 to 39.9 kg/m2 [15], of any race,
and aged between 23 and 59 years. Those women with
clinical diagnosis of diabetes mellitus, who used vitamin
supplements, with presence of renal, liver, or heart failure,
and who were pregnant and lactating were excluded.
General information about age, smoking habit, socioeco-
nomic status, family history, medical history, and the use of
supplements and drugs were obtained through a question-
naire developed by the researchers.
2.3. Nutrient intake
The usual dietary intakes of folic acid, cobalamin,
pyridoxine, cholesterol, fiber, alcohol, and coffee were
assessed through the FFQ (which contains 81 food items)
[14] because these can influence Hcy levels in accordance to
scientific literature.
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acid was not considered in the analysis of the FFQ, whereas
in the postfortification group, fortified food with folic acid
was considered. Nutrient analysis was performed using the
program “The Food Processor” (Esha Research, Salem,
Mass, USA) [16], adapted to the Brazilian reality.
The evaluation of the folic acid content in the preforti-
fication group, selected in the program Food Processor food,
was not fortified with this vitamin. For the postfortification
group, we used food fortified with folic acid.2.4. Clinical and anthropometric measurements
Body weight (kilograms) and height (meters) were
measured using the Filizola platform scale and a Filizola
vertical stadiometer, respectively [17]. Body mass index was
calculated as weight divided by square height (kg/m2) [15].
Waist circumference was measured at the midpoint between
the last rib and the iliac crest using an inelastic metric tape
[18]. The pressure levels were measured with a mercury
sphygmomanometer [19].2.5. Biochemical measurements
Blood samples were drawn after a 12-hour overnight fast
and were placed into tubes that did not contain anticoagulant
or with ethylene diamine tetra-acetic acid (Vacutainer,
Becton Dickinson, NJ, USA). Aliquots of serum and plasma
samples were obtained by centrifugation at 4000 rpm for 15
minutes (Centrifuge Excelsa Baby I; Fanem, São Paulo,
Brazil) and stored at −20°C until analysis. The analyses of
the prefortification group were performed at the end of the
blood draw from all participants in 2003, and the analyses of
the postfortification group were performed at the end of the
blood draw of all participants in 2009.
Serum concentrations of glucose [20], triglycerides [21],
high-density lipoprotein cholesterol (HDL-C) [22], and total
cholesterol [23] were determined by enzymatic method,
according to the manufacturer's instructions (CELM and
KATAL kits; Katal Biotechnologica, Ind, Com, Ltda, Minas
Gerais, Brazil, and CELM-Cia; Equipadora de Laboratories,
Moderneros-Sao Paulo, Brazil). The following values were
considered normal as indicated by the manufacturers:
glucose less than 100 mg/dL, triglycerides less than 150
mg/dL, HDL-C greater than 50 mg/dL, and total cholesterol
less than 200 mg/dL. Low-density lipoprotein cholesterol
(LDL-C) was calculated [24], the ideal reference value being
less than 100 mg/dL.
Plasma concentrations of cobalamin were determined by
automated chemiluminescence method, using the IMMU-
LITE 2000 kit (Siemens AG, Munich, Germany), with
normal values greater than 120 pmol/L [25]. Concentrations
of plasma folate and Hcy were determined by competitive
immunoassay [26] with the IMMULITE kit, with the values
greater than 7 nmol/L and less than 10 mmol/L, respectively,
which were considered as appropriate values [25,27].2.6. Ethical aspects
The women were fully informed about all the procedures
before they signed a statement of consent. The protocols of
both studies (CEP: 017/03 and CEP: 017/08, respectively)
were approved by the Research Ethics Committee of
Clementino Fraga Filho University Hospital at the Federal
University of Rio de Janeiro.
2.7. Statistical analyses
Data are presented as means, SDs, medians, P25, and P75.
The groups were compared using the Mann-Whitney U test.
To verify a statistically significant association between
categorical variables according to the classical cutoffs, the
χ2 test was used to compare the 2 groups. In addition, we
carried out the adjustment for age for the Hcy, cobalamin,
dietary, and serum folate by linear regression. The Spearman
correlation was calculated between continuous variables in
both groups. Statistical analysis was performed using the
Statistical Package for Social Sciences for Windows version
17.0 (SPSS, Inc, Chicago, Ill, USA) [28]. Differences were
considered significant at P b .05.3. Results
A total of 93 women (38 prefortification and 55
postfortification) were included in the study. The partici-
pants' average age was 48.1 ± 9.5 years, with a median of
51 years, in the prefortification group, and 39.1 ± 4.1 years,
with a median of 40 years, in the postfortification group
(P b .001).
Both groups were obese class 1 [15], characterized by the
accumulation of visceral fat [29], with average BMI of 31.9
and 32.8 kg/m2 and waist circumference of 100.7 and 101.6
cm in the prefortification and postfortification groups,
respectively.
Table 1 shows biochemical and dietary variables in
prefortification and postfortification of flours with folic acid
and the percentages of the adequacy in the same variables. In
the prefortification group, 71.1% (n = 27) of the women had
a lower dietary intake of folate than the current recom-
mended for adults (b400 μg/d), whereas in the postfortifica-
tion group, only 16.4% (n = 9) of the women had lower
intakes than recommended [30]. In the prefortification
group, 42.1% (n = 16) of the women had hyperhomocys-
teinemia (N10 μmol/L) [27], against only 9.1% (n = 5) in the
postfortification group. Differences were also found between
the 2 groups for the following continuous variables: total
cholesterol, HDL-C, triglycerides, and dietary fiber.
Table 2 shows the Spearman rank correlation coefficient
for clinical and dietary characteristics in relation to variable
Hcy, with significant correlations marked in bold. In the
prefortification group, plasma concentrations of Hcy corre-
lated positively with age. In the postfortification group, total
Hcy levels were negatively correlated with HDL-C and
Table 1
Biochemical and dietary variables of subjects prefortification and postfortification of flours with folic acid
Measurements Prefortification (n = 38) Postfortification (n = 55)
Mean SD Median P25 P75 % adequacy a Mean SD Median P25 P75 % adequacy a P
Dietary variables (n = 38) (n = 55)
Folate, μg/d 317.0 136.9 319.1 197.9 437.6 28.9 641.7 248.7 642.9 434.2 826.6 83.6 b.001
Cobalamin, μg/d 5.6 6.0 3.5 2.6 5.3 78.9 6.2 6.7 4.5 2.6 7.3 80.0 .323
Pyridoxine, mg/d 1.4 0.6 1.3 1.0 1.6 44.7 1.7 0.6 1.7 1.3 2.0 76.4 .003
Cholesterol, mg/d 270.2 168.7 249.2 165.3 355.9 71.1 328.9 185.0 290.6 221.4 369.7 52.7 .040
Fiber, g/d 19.1 11.4 16.7 14.2 22.9 13.2 42.1 16.2 41.0 30.0 54.1 83.6 b.001
Alcohol, g/d 1.7 4.9 0.0 0.0 0.0 97.7 3.6 5.9 0.6 0.0 4.9 90.9 .002
Caffeine, mg/d 54.9 30.4 52.7 33.5 68.9 89.5 114.9 87.4 101.9 59.1 135.0 41.8 b.001
Biochemical variables
Total cholesterol , mg/dL 257.0 70.7 274.7 195.8 318.0 28.9 190.9 31.5 188.5 168.0 212.0 63.6 b.001
HDL-C, mg/dL 37.1 8.2 35.3 31.1 41.4 7.9 52.3 11.0 52.0 42.0 62.0 58.2 b.001
LDL-C, mg/dL 175,2 61.9 198.6 126.8 216.8 16.2 111.0 29.8 112.3 92.8 128.9 33.3 b.001
Triglycerides, mg/dL 208.2 89.2 204.7 148.5 259.3 26.3 142.5 101.0 110.0 77.0 169.0 67.3 b.001
Glucose, mg/dL 85.8 19.0 82.1 75.4 98.4 78.9 86.7 11.1 85.0 80.0 91.0 90.9 .430
Plasma folate, nmol/L 15.7 10.7 13.78 9.1 17.4 80.6 12.1 3.8 11.6 9.4 14.4 92.7 .193
Plasma cobalamin, pmol/L 362.3 257.9 285.35 106.2 596.6 72.4 465.0 362.3 426.5 275.0 563.0 98.2 .049
Hcy, μmol/L 9.5 2.7 9.1 6.9 11.7 57.9 6.1 3.6 5.5 4.2 6.8 90.9 b.001
Values are expressed in mean, SD, and median (compared by Mann-Whitney U test). P b .05, significant difference between groups. Dietary variables: folate
greater than 400 μg/d; cobalamin greater than 2.4 μg/d; pyridoxine less than 50 years, greater than 1.3 mg/d, greater than 51 years, greater than 1.5 mg/d;
cholesterol less than 300 mg/d; fiber greater than 25g/d; alcohol less than 15g/d; caffeine less than 89 mg/d. Biochemical variables: total cholesterol less than
200 mg/dL; HDL-C greater than 50 mg/dL; LDL-C less than 100 mg/dL; triglycerides less than 150 mg/dL; glucose less than 100 mg/dL; plasma folate greater
than 7 nmol/L; plasma cobalamin greater than 120 pmol/L; Hcy less than 10 μmol/L.
a Cut points for each variable, representing the proportion of adequate.
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circumference.
The difference of the mean adjusted by age in the
main variables, prefortification and postfortification of
flours with folic acid, is presented on Table 3. The
mean of plasma Hcy levels, when adjusted by age, was
2.5 mmol/L lower in the postfortification group in relationTable 2
Spearman rank correlation coefficient for clinical and dietary characteristics
of subjects in relation to Hcy





r P r P
Total cholesterol, mg/dL 0.030 .859 0.171 .212
HDL-C, mg/dL −0.150 .368 −0.280 .038
LDL-C, mg/dL 0.047 .780 0.216 .116
Triglycerides, mg/dL 0.145 .386 0,274 .043
Glucose, mg/dL 0.140 .401 0.347 .009
Cobalamin, pmol/L −0.093 .633 0.042 .763
BMI, kg/m2 −0.031 .855 −0.042 .760
Waist circumference, cm −0.368 .023 0.299 .027
Fiber dietary, g/d −0.029 .862 −0.115 .402
Cholesterol dietary, g/d −0.128 .444 0.000 .999
Pyridoxine dietary, mg/d −0.052 .757 −0.222 .103
Cobalamin dietary, μg/d −0.152 .362 0.120 .381
Alcohol dietary, g/d 0.242 .144 −0.029 .832
Folate dietary, μg/d −0.053 .750 −0.041 .767
Caffeine dietary, g/d 0.104 .535 0.039 .779
Age, y 0.322 .049 0.158 .250
P b .05, statistically significant correlation.to the prefortification group, with statistically significant
difference between groups.
Fig. 1 shows the correlation between Hcy with folate
intake prefortification and postfortification of flours, with
plasma Hcy levels decreasing proportionally to increased
intake of folate in both groups.
Fig. 2 shows the correlation of Hcy levels with plasma
folate prefortification and postfortification of flours. Plasma
Hcy decreased with increasing plasma concentrations of
folate, but the reduction of Hcy was more accentuated in the
postfortification group.4. Discussion
Because of the lower bioavailability of folic acid from
food, it is unlikely that only a diet could be sufficient to
increase the plasma concentrations of folate and reduce the
concentration of Hcy [3].
US folic acid fortification of enriched cereal grain
products is credited with an increase in blood folate
concentrations and in reducing the risk of cardiovascular
disease and stroke [31]; however, more research is needed to
know for sure. Along with these benefits, concerns have also
been raised about the potential for adverse effects of high
levels of folic acid, such as increased risks of certain cancers,
the exacerbation of neurologic effects from exposure to very
high doses of folic acid, and cognitive decline [31,32].
Although folic acid is safe and almost free of toxicity,
fortification with folic acid might mask symptoms of
Table 3
Mean adjusted by age of subjects by the main variables, prefortification and postfortification of flours with folic acid
Prefortification (n = 38) Postfortification (n = 55) Prefortification vs postfortification









Hcy, μmol/L 9.5 2.7 6.1 3.6 −3.4 −2.5 .003
Plasma folate, nmol/L 15.7 10.7 12.1 3.8 −3.6 −6.0 .002
Plasma cobalamin, pmol/L 362.3 257.9 465.0 362.3 102.8 0.1 .952
Dietary folate, μg/d 317.0 136.9 641.7 248.7 324.7 302.5 b.001
P b .05, significant difference between groups.
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contributing to the development of progressive and irrevers-
ible neurologic damage. This problem could be solved with
double fortification with folate and cobalamin [33], but in
Brazil, the fortification was made with folic acid and iron.
The previous reports explain the discrepancy between the
epidemiological observations that suggest a reduction of
cardiovascular risk in North America after folic acid
fortification and an emerging body of evidence that folic
acid supplementation may enhance the development and
progression of adverse effects on most of the population that
are not the main target of the fortification [31].
In our study of both groups, we found a significant
positive correlation between the consumption of folate,
pyridoxine, and dietary fiber, which were also the results
observed in a Norwegian study that included 5812 men and
women, in which the consumption of these vitamins was
positively correlated with the intake of vegetables, fruits,
fiber, and most vitamins [34].
Data of Pesquisa de Orçamentos Familiares 2008-2009
[35] show an increase of 9.52% in fruit consumption and
10% in consumption of vegetables by the Brazilian
population, compared with the period 2002 to 2003,
which corresponds to the groups prefortification and 
Post-fortification
r=-0.041; P = .767
Pre-fortification       r=-0.053; P = .750 
Folate Intake (µg/d)
Plasma total Homocysteine (µmol/L) 
Pre-fortification
Post-fortification












Fig. 1. Correlation between Hcy with folate intake of subjects prefortifica-
tion and postfortification of flours.postfortification, corroborating the significant increase in
the dietary intake of folate, pyridoxine, and fiber found in
the postfortification group. Our findings show that after
fortification, 83.6% of volunteers had an adequate dietary
intake of folate in contrast to only 28.9% in the
prefortification group, a fact that indicates the beneficial
effect of fortification.
In the postfortification group, 98.2% and 92.7% of
volunteers showed adequate plasmatic concentrations of
cobalamin and folate, respectively, whereas in the preforti-
fication group, these percentages were 72.4% and 80.6%,
respectively. Similar results were found in a study of children
in the United States, which showed that after fortification,
the intake of cereals ready for consumption or supplements
containing folic acid increased the daily intake and serum
concentrations of folate and cobalamin [36]. Selhub et al
[37], in a study on the US population before and after
fortification, showed that Hcy levels do not generally
decrease with increasing concentrations of folate among
persons with low serum cobalamin. On the other hand, an
intervention study conducted with healthy male subjects
showed that a system of fortification with 200 μg/d of folic
acid, which can be achieved by food fortification, would be
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Pre-fortification  r=-0.318; P = .059 
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Fig. 2. Correlation of Hcy levels in plasma of subjects, folate prefortification
and postfortification of flours.
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tions and the practice of physical activity; the same result
was observed in another study in adults of both sexes,
without any chronic illness, in Greece [39].
Observational study in humans showed an inverse
correlation between the concentrations of Hcy and HDL-C,
an inverse association between HDL-C and CVD, and a
positive correlation between Hcy and CVD [40]. The results
of the present study showed an inverse correlation, although
not significant, between Hcy concentration and the concen-
tration of HDL-C, possibly because the sample was smaller.
The differences between the 2 groups in concentrations of
total cholesterol, HDL-C, triglycerides, and dietary fiber
suggest greater cardiovascular protection in the postfortifica-
tion group, possibly due to an increased consumption of food
rich in fiber.
Nevertheless, it is necessary to point out some limitations
of this research. The studies from which the selected women
were included were not developed for this purpose and the
members of the 2 groups were not the same. However, all
procedures were performed with the same technique,
equipment, and by the same researchers in both groups.
The women from the prefortification group were much older
than those from the postfortification group. The Hcy
difference found in both groups could have resulted from
age difference. To minimize the limitation of age difference
between the 2 groups, the main study variables were adjusted
by age. The analysis of folate in erythrocytes was not carried
out due to unavailability of the analysis in both groups.
In conclusion, our findings corroborate the hypothesis
that fortification of wheat and corn flours with folic acid can
be possibly associated with lower concentrations of plasma
Hcy, providing probable greater cardiovascular protection in
the postfortification group. Further studies are needed to
monitor the optimum amount of folic acid to be used for
fortification and verify whether these programs will result in
decreased cardiovascular risk in the future.Acknowledgment
The authors thank the Fundação de Amparo à Pesquisa do
Estado do Rio de Janeiro (Research funding agency of the
State of Rio de Janeiro) and Coordenação de Aperfeiçoa-
mento de Pessoal de Nível Superior (government agency
linked to the Brazilian Ministry of Education in charge of
promoting high standards for postgraduate courses in Brazil)
for financial support.References
[1] Influence of folic acid on plasma homocysteine levels & arterial
endothelial function in patients with unstable angina Hangyuan Guo,
Jufang Chi, Yangbo Xing & Ping Wang. Indian J Med Res 2009;129:
279-84.
[2] Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid
supplementation on risk of cardiovascular diseases. A meta-analysis ofrandomized controlled trials. JAMA 2006;296:2720-6. Downloaded
from jama.ama-assn.org by guest on February 2, 2011.
[3] Uehara SK, Rosa G. Associação da deficiência de ácido fólico com
alterações patológicas e estratégias para sua prevenção: uma visão
crítica. Rev Nutr 2010;23:881-94.
[4] Wald DS, Law M, Morris JK. Homocysteine and cardiovascular
disease: evidence from a metaanalysis. BMJ 2002;325:1202-9.
[5] Bailey LB. Dietary reference intakes for folate: the debut of dietary
folate equivalents. Nutr Rev 1998;56:294-9.
[6] Garcia-Arias MT, Villarino Rodriguez A, Garcia-Linares MC,
Rocandio AM, Garcia-Fernandez MC. Iron, folate and vitamins B12
& C dietary intake of elderly institutionalized population in Leon,
Spain. Nutr Hosp 2003;18:222-5.
[7] Paz R, Hernandez-Navarro F. Manejo, prevención y control de la
anemiamegaloblástica secundaria a déficit de ácido fólico. Nutr Hosp
2006;21:113-9.
[8] Food and Drug Administration. Food standards: amendment of
standards of identity for enriched grain products to require addition
of folic acid. Fed Regist 1996;61:8781-97.
[9] Agência Nacional de Vigilância Sanitária. Aprova o regulamento
técnico para a fortificação das farinhas de trigo e das farinhas de milho
com ferro e ácido fólico. RDC n. 344, de 13 de dezembro de; 2002.
[10] Soeiro BT, Boen TR, Wagner R, Lima-Pallone JA. Physico-chemical
quality and homogeneity of folic acid and iron in enriched flour using
principal component analysis. Int J Food Sci Nutr 2009;60(Suppl 7):
167-79.
[11] Antoniades C, Antonopoulos AC, Tousoulis D, Marinou K, Stefanadis
K. Homocysteine and coronary atherosclerosis: from folate fortifica-
tion to the recent clinical trials. Eur Heart J 2009;30:6-15.
[12] Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosemberg IH.
The effect of folate acid fortification on plasma folate and total
homocysteine concentrations. N Engl J Med 1999;340:1449-54.
[13] Uehara SK, Rosa G. Association of homocysteinemia with high
concentrations of serum insulin and uric acid in Brazilian subjects
with metabolic syndrome genotyped for C677T polymorphism in
the methylenetetrahydrofolate reductase gene. Nutr Res 2008;28:
760-6.
[14] Sichieri R, Everhart JE. Validity of a Brazilian food frequency
questionnaire against dietary recalls on estimated energy intake. Nutr
Res 1998;18:1649-59.
[15] WHO. Obesity: prevention and managing the global epidemic: report
of a WHO consultation on obesity; Geneva; 1998.
[16] Food Processor Nutrition Analysis System. Version 12.0. USA: ESHA
Corporation; 1984.
[17] Gibson RS. Principles of nutritional assessment. New York: Oxford
University Press; 1990.
[18] WHO. Obesity: preventing and managing the global epidemic: report
of a WHO consultation. Geneva; 2000.
[19] Pickering TG, Hall JE, Lawrence JÁ, Falkner BE, Graves J, Hill MN.
Recommendation for blood pressure measurement in humans and
experimental animals. Part 1: blood pressure measurement in humans.
A statement for professionals from the subcommittee of professional
and public education of the American Heart Association Council on
High Blood Pressure Research. Circulation 2005;45:142-61.
[20] Trinder P. Determination of glucose in blood using glucose oxidase
with an alternative oxygen acceptor. Ann Clin Biochem 1969;6:24-5.
[21] Fossati, Prencipe L. Serum triglycerides determined colorimetrically
with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28
(10):2077-80.
[22] Warnick GR, Nauck M, Rifai N. Evolution of methods for
measurement of HDL-cholesterol: from ultracentrifugation to homo-
geneous assays. Clin Chem 2001;47(9):1579-96.
[23] Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic
determination of total serum cholesterol. Clin Chem 1974;20(4):470-5.
[24] Friedwald WT, Levy RI, Fredrickson DS. Estimation of the
concentration of low-density lipoprotein cholesterol in plasma, without
use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
895M. Scorsatto et al. / Nutrition Research 31 (2011) 889–895[25] Institute of Medicine/Food and Nutrition Board. Dietary reference
intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12,
pantothenic acid, biotin, and choline. Washington, DC: National
Academy Press; 1998.
[26] Ueland PM, Refsum H, Stabler SP. Total homocysteine in plasma or
serum: methods and applications. Clin Chem 1993;39:1764-79.
[27] Omenn GS, Beresford SAA, Motulsky AG. Preventing coronary heart
disease—B vitamins and homocysteine. Circulation 1998;97:421-4.
[28] Statistical Package for the Social Sciences (SPSS) 11.0 for Windows.
Chicago: SPSS Inc; 2001.
[29] The IDF worldwide definition of the metabolic syndrome. 2005.
[Accessed 2011 February 4]. Available from: http://www.idf.org/
home/index.cfm?node=1429.
[30] Institute of Medicine/Food and Nutrition Board. Dietary reference
intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12,
pantothenic acid, biotin, and choline. Washington, DC: National
Academy Press; 2000.
[31] Yang Q, Botto LD, Erickson JD, et al. Improvement in stroke mortality
in Canada and the United States, 1990 to 2002. Circulation 2006;113:
1335-43.
[32] Tighe P, WardM,McNulty H, Finnegan O, Dunne A, Strain JJ, et al. A
dose-finding trial of the effect of long-term folic acid intervention:
implications for food fortification policy. Am J Clin Nutr 2011;93:
11-8.
[33] Campbell NR. How safe are folic acid supplements? Arch Intern Med
1996;156:1638-44.[34] Konstantinova SV, Vollset SM, Berstad P, Ueland PM, Drevon CA,
Refsum H, et al. Dietary predictors of plasma total homocysteine in
the Hordaland Homocysteine Study. Br J Nutr 2007;98:201-10.
[35] IBGE – Instituto Brasileiro de Geografia e Estatística, Diretoria de
Pesquisas, Coordenação de trabalho e rendimento, Pesquisa de
Orçamentos Familiares (POF) 2002-2003/2008-2009. Rio de Janeiro:
IBGE; 2010.
[36] Yeung LF, Cogswell ME, Carriquiry AL, Bailey LB, Pfeiffer CM,
Berry RJ. Contributions of enriched cereal-grain products, ready-to-eat
cereals. and supplements to folic acid and vitamin B-12 usual intake
and folate and vitamin B-12 status in US children: National Health and
Nutrition Examination Survey (NHANES), 2003–2006. Am J Clin
Nutr 2011;93:172-85.
[37] Selhub J, Morris MS, Jacques PF. In vitamin B12 deficiency, higher
serum folate is associated with increased total homocysteine and
methylmalonic acid concentrations. PNAS 2007;104:19995-20000.
[38] Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG, Scott JM.
Plasma homocysteine, a risk factor for cardiovascular. Q J Med 1997;
90:519-24.
[39] Chrysohoou C, Panagiotakos DB, Pitsavos C, Zeimbekis A, Zampelas
A, Papademetriou L, et al. The associations between smoking, physical
activity, dietary habits and plasma homocysteine levels in cardiovas-
cular disease-free people: the “ATTICA” study. Vasc Med 2004;9:
117-23.
[40] Barter PJ, Rye KA. Homocysteine and cardiovascular disease is HDL
the link? Circ Res 2006;99:565-6.
